(WMD:Stuttgart Stock Exchange)
Lynn Seely M.D.
Chief Medical Officer, Medivation, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2014
Dr. Lynn Seely, M.D. has been the Chief Medical Officer of Medivation, Inc. (Formerly Orion Acquisition Corp. II) since May 9, 2005. Dr. Seely is responsible for the strategy and execution of Orion Acquisition Corp. II's clinical development programs, and for assisting in the evaluation of new opportunities to expand. Dr. Seely served as Vice President of Clinical Development at Corgentech Inc., from 2002 to 2005, At Corgentech, Dr. Seely was responsible for all aspects ...
525 Market StreetPhone: 415-543-3470
San Francisco, California 94105
Board Members Memberships*There is no Board Members Memberships data available.
Oklahoma City University
College of Medicine at the University of Oklahoma
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Clay B. Siegall Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Seattle Genetics, Inc.
|Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.||Managing Director, Vice President of South Asia, Global Operations, Executive Director, Member of Audit Committee and Member of Corporate Social Responsibility Committee|
Sanofi India Limited
|Aijaz Tobaccowalla||Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee|
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$889.2K||Compensation as of Fiscal Year 2014.|